STOCK TITAN
  1. Home
  2. Sec-filings
  3. BCTX
  4. [EFFECT] BriaCell Therapeutics Corp. SEC Filing

[EFFECT] BriaCell Therapeutics Corp. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 13, 2026 5:00 P.M.
Form: S-1
CIK: 0001610820
Company Name: BriaCell Therapeutics Corp.
File Number: 333-292388

Source: View Original Filing on SEC EDGAR

Stock BCTX logo
Briacell Therapeutics Corp

NASDAQ:BCTX

BCTX Rankings

#6418 Ranked by Market Cap
N/A Ranked by Dividends

BCTX Latest News

Jan 13, 2026
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient
Dec 18, 2025
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
Dec 10, 2025
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
Dec 9, 2025
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Dec 2, 2025
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

BCTX Latest SEC Filings

Jan 15, 2026
[8-K] BriaCell Therapeutics Corp. Reports Material Event
Dec 29, 2025
[8-K] BriaCell Therapeutics Corp. Reports Material Event
Dec 11, 2025
[10-Q] BriaCell Therapeutics Corp. Quarterly Earnings Report
Oct 16, 2025
[10-K] BriaCell Therapeutics Corp. Files Annual Report
Oct 10, 2025
[SCHEDULE 13G] BriaCell Therapeutics Corp. SEC Filing

BCTX Stock Data

8.46M
1.86M
2.55%
9.66%
1.32%
Biotechnology
Pharmaceutical Preparations
Link
Canada
WEST VANCOUVER